Biomarkers for Oncology
JH · Effective Oct 1, 2015
30 active Medicare policies list E04.1, and 2 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 13, 2024
JE · Effective Jul 28, 2024
JF · Effective Jul 28, 2024
2 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of E04.1 |
|---|---|---|
| Prolotherapy and Sclerotherapy | Apr 11, 2023 | Covered |
| Policy | Effective | Status of E04.1 |
|---|---|---|
| Concert Genetic Testing Oncology: Algorithmic Assays | Not recorded | Referenced |
JJ · Effective Jul 28, 2024
JM · Effective Jul 28, 2024
J5 · Effective Jul 28, 2024
J8 · Effective Jul 28, 2024
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
J9 · Effective Oct 1, 2015
J6 · Effective Dec 1, 2021
JK · Effective Dec 1, 2021
J9 · Effective Oct 1, 2015
JL · Effective Apr 24, 2025
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Jul 28, 2024
National · Effective May 22, 2025
National · Effective Feb 5, 2026
J5 · Effective Apr 16, 2026
National · Effective Oct 1, 2026
J9 · Effective Oct 1, 2024
J6 · Effective Apr 1, 2026
J9 · Effective Oct 1, 2022